InspireMD, Inc. (NSPR) › Cash & EquivalentsInspireMD, Inc. (NSPR) — Cash & EquivalentsAnnual figures by fiscal year, from SEC filings.2008: $1.57M2009: $376.0K2010: $636.0K2011: $5.09M2012: $10.28M2013: $17.54M2014: $6.30M2015: $3.26M2016: $7.52M2017: $3.71M2018: $9.38M2019: $5.51M2020: $12.64M2021: $12.00M2022: $4.63M2023: $9.64M2024: $18.92M2025: $8.94M$8.94M2008Cash & Equivalents (USD)2025Fiscal YearCash & EquivalentsChange YoY2025$8.94M-52.7%2024$18.92M+96.2%2023$9.64M+108.1%2022$4.63M-61.4%2021$12.00M-5.1%2020$12.64M+129.3%2019$5.51M-41.2%2018$9.38M+152.9%2017$3.71M-50.6%2016$7.52M+130.8%2015$3.26M-48.3%2014$6.30M-64.1%2013$17.54M+70.5%2012$10.28M+101.9%2011$5.09M+700.9%2010$636.0K+69.1%2009$376.0K-76.1%2008$1.57M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share